Making pharmacogenetic testing a reality in a community pharmacy

Journal of the American Pharmacists Association

Volumn 52, Issue 6, 2012, Pages

  O'Connor, Shanna K ^a   Ferreri, Stefanie P ^b   Michaels, Natasha M ^c   Chater, Rebecca W ^d   Viera, Anthony J ^e   Faruki, Hawazin ^f   McLeod, Howard L ^g   Roederer, Mary ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c Kerr Drug Inc   (United States)

^d Kerr Drug Inc   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f Clinical Development with Laboratory Corporation   (United States)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Clinical pharmacy service; Community pharmacy; Community pharmacy services; Medication therapy management; Pharmacogenetics; Pharmacogenomics

Indexed keywords

ARTICLE; BILLING AND CLAIMS; BLOOD PRESSURE MONITORING; CLINICAL PRACTICE; COMPUTER PROGRAM; DIABETES EDUCATION; DOCUMENTATION; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH SERVICE; HUMAN; IMMUNIZATION; MEDICAL RECORD; MEDICATION THERAPY MANAGEMENT; PHARMACIST; PHARMACOGENETICS; PHARMACY; POINT OF CARE TESTING; POSTGRADUATE EDUCATION; PRESCRIPTION; PROFESSIONAL KNOWLEDGE; REIMBURSEMENT; RESIDENT; TRAINING;

EID: 84890955122     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2012.12108     Document Type: Article

References (17)

1. Reiss SM; American Pharmacists Association. Integrating pharmacogenomics into pharmacy practice via medication therapy management. J Am Pharm Assoc. 2011;51:e64-74.
2. Government Accountability Office. Direct-to-consumer genetic tests: misleading test results are further complicated by deceptive marketing and other questionable practices. Accessed at www.gao.gov/new.items/d10847t.pdf, Feb 29, 2011.
3. Vorhaus D. Transparency first: a proposal for DTC genetic testing regulation. Accessed at www.genomicslawreport.com/index,php/2010/05/24/ transparency-first-a-proposal-for-dtc-genetic-testing-regulation/, February 29, 2011.
4. Secretary's Advisory Committee on Genetics, Health and Society. Realizing the potential of pharmacogenomics: opportunities and challenges. Accessed at http://oba.od.nih.gov/oba/SACGHS/reports/SACGHS-PGx-report.pdf, Feb 29, 2011.
5. Feero WG, Green ED. Genomics education for health care professionals in the 21st century. JAMA. 2011;306:989-90.
6. Food and Drug Administration. Table of pharmacogenomic biomarkers in drug labels. Accessed at www.fda.gov/drugs/scienceresearch/researchareas/ pharmacogenetics/ucm083378.htm, Mar 1, 2012.
7. Frueh FW, Amur S, Mummaneni P, et al. Pharmacogenomic biomarker information in drug labels approved by the United States Food and Drug Administration: prevalence of related drug use. Pharmacotherapy. 2008;28:992-8.
8. Epstein RS, Moyer TP, Aubert RE. Warfarin genotyping reduces hospitalization rates: results from the MM-WES (Medco-Mayo Warfarin Effectiveness Study). J Am Coll Cardiol. 2010;55:2804-12.
9. Mallal S, Phillips E, Carosi G, et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med. 2008;358:568-79.
10. Padgett L, O'Connor S, Roederer M, et al. Pharmacogenomics in a community pharmacy: ACT now. J Am Pharm Assoc. 2010;51:189-93,
11. Schommer JC, Doucette WR, Johnson KA, et al. Position-ing and integrating medication therapy management. J Am Pharm Assoc. 2012;52:e1-13.
12. O'Connor SK, Ferreri SP, Michaels NM, et al. Exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy. Pharmacogenomics. 2012;13:955-62.
13. Crews KR, Cross SJ, McCormick JN, et al. Development and implementation of a pharmacist-managed clinical pharmacogenetics service. Am J Health Syst Pharm. 2011;68:143-50.
14. Snyder B. Scripps Research and Vanderbilt launch joint institute to advance science at interface of chemistry and medicine. Accessed at http://news.vanderbilt.edu/2011/01/scripps-research-and-vanderbilt-launch-joint- institute-to-advance-science-at-interface-of-chemistry-and-medicine/, March 1, 2012.
15. Overby CL, Tarczy-Hornoch P, Hoath JI, et al. Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support. BMC Bioinformatics. 2010;11(suppl 9):s10.
16. Scott SA, Sangkuhl K, Gardner EE, et al. Clinical pharmacogenetics implementation consortium guidelines for cytochrome P450-2C19 genotype and clopidogrel therapy. Clin Pharmacol Ther. 2011;90:328-32.
17. DaVanzo J, Dobson A, Koenig L, Book R. MTM services: a critical review. Accessed at www.accp.com/docs/positions/commentaries/mtms.pdf, Feb 15, 2012.